Therefore, while compounds that activate Nrf2 have the potential to be beneficial in neurodegenerative diseases such as Alzheimer’s, it is also critical to consider the risks associated with prolonged Nrf2 activation, especially in the context of oncogenesis. This evidence concerns the gene NFE2L2 and neurodegenerative disease.